pharmaceutical investing Melinta Therapeutics Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE
Term Sheet to Treat Colorado Project Uranium Waste Dumps and Gross Revenue Sharing Agreement with DISA Technologies